Icosavax Inc (ICVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,758 | -66,971 | -18,854 | N/A | N/A |
| Depreciation Amortization | -668 | 82 | 1 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,195 | 1,839 | 1,119 | N/A | N/A |
| Other Working Capital | 8,074 | -1,905 | 4,158 | N/A | N/A |
| Other Operating Activity | 23,872 | 28,415 | -632 | 0 | 0 |
| Operating Cash Flow | $-61,675 | $-38,540 | $-14,208 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -158,336 | 0 | N/A | N/A | N/A |
| PPE Investments | -11,113 | -1,006 | -11 | N/A | N/A |
| Investing Cash Flow | $-169,449 | $-1,006 | $-11 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 6,464 | N/A | N/A |
| Common Stock Issued | 10,307 | 400 | 174 | N/A | N/A |
| Other Financing Activity | 0 | 304,372 | 0 | 0 | 0 |
| Financing Cash Flow | $10,307 | $304,772 | $6,638 | $N/A | $N/A |
| Beginning Cash Position | 280,724 | 15,498 | 23,079 | N/A | N/A |
| End Cash Position | 59,907 | 280,724 | 15,498 | N/A | N/A |
| Net Cash Flow | $-220,817 | $265,226 | $-7,581 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,675 | -38,540 | -14,208 | N/A | N/A |
| Capital Expenditure | -11,113 | -1,006 | -11 | N/A | N/A |
| Free Cash Flow | -72,788 | -39,546 | -14,219 | 0 | 0 |